Portfolio Prioritization for Large and Small Pharma Using Early-Stage Biosimulation On-Demand Webinar Portfolio Prioritization for Large and Small Pharma Using Early-Stage Biosimulation Learn how early-stage biosimulation and mechanistic modeling enable smarter portfolio prioritization before IND-enabling studies. Watch…Certara2026 年 3 月 25 日
ADC Development & Differentiation Strategies | Quantitative Systems Pharmacology & MIDD Video ADC Development & Differentiation Strategies | Quantitative Systems Pharmacology & MIDD Learn how model-informed drug development (MIDD) and quantitative systems pharmacology (QSP) support antibody-drug conjugate (ADC)…Certara2026 年 3 月 13 日
Discovery & Development Europe 2026 Conference Discovery & Development Europe 2026 Certara2026 年 3 月 13 日
Maximizing the Impact of Antibody–Drug Conjugates (ADCs): Model-Informed Labeling, Expansion, and Market Access Webinar Maximizing the Impact of Antibody–Drug Conjugates (ADCs): Model-Informed Labeling, Expansion, and Market Access Danielle Pillsbury2026 年 2 月 23 日
Optimal Dosing, Optimal Outcomes: Model-Based Approaches for Antibody–Drug Conjugates (ADCs) Webinar Optimal Dosing, Optimal Outcomes: Model-Based Approaches for Antibody–Drug Conjugates (ADCs) Certara2026 年 2 月 23 日
Strong starts, confident finishes: Optimizing first-in-human strategies for antibody–drug conjugates (ADCs) Webinar Strong starts, confident finishes: Optimizing first-in-human strategies for antibody–drug conjugates (ADCs) Certara2026 年 2 月 23 日
Accelerate Decisions with Certara IQ™: Scalable, AI-Driven QSP for Drug Development On-Demand Webinar Accelerate Decisions with Certara IQ™: Scalable, AI-Driven QSP for Drug Development Discover how Certara's AI-powered QSP modeling software, Certara IQ is overcoming challenges in drug development…Certara2026 年 2 月 17 日
Certara IQ™ Global Roadshow Live Events Certara IQ™ Global Roadshow Certara IQ™ is going on the road. From APAC to Europe to North America, our…Certara2026 年 2 月 12 日
Anti-PD-(L)1 Antibodies: Insights From QSP-Based Meta-Analysis Publication Anti-PD-(L)1 Antibodies: Insights From QSP-Based Meta-Analysis Anti-PD-1 and anti-PD-L1 antibodies have transformed cancer immunotherapy, yet clinical meta-analyses suggest differences in efficacy…Certara2026 年 2 月 11 日